Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Carmeliet, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 163 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tanaka, M; Okada, K; Ueshima, S; Imano, M; Ohyanagi, H; Carmeliet, P; Matsuo, O
      Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice

      FIBRINOLYSIS & PROTEOLYSIS
    2. Carmeliet, P; Conway, EM
      Growing better blood vessels - A polymer scaffold that delivers two angiogenic factors with distinct kinetics shows promise for engineering mature blood vessels

      NATURE BIOTECHNOLOGY
    3. Nuyens, D; Stengl, M; Dugarmaa, S; Rossenbacker, T; Compernolle, V; Rudy, Y; Smits, JF; Flameng, W; Clancy, CE; Moons, L; Vos, MA; Dewerchin, M; Benndorf, K; Collen, D; Carmeliet, E; Carmeliet, P
      Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome

      NATURE MEDICINE
    4. Brown, EB; Campbell, RB; Tsuzuki, Y; Xu, L; Carmeliet, P; Fukumura, D; Jain, RK
      In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy (vol 7, pg 864,2001)

      NATURE MEDICINE
    5. Brown, EB; Campbell, RB; Tsuzuki, Y; Xu, L; Carmeliet, P; Fukumura, D; Jain, RK
      In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy

      NATURE MEDICINE
    6. Carmeliet, P; Moons, L; Luttun, A; Vincenti, V; Compernolle, V; De Mol, M; Wu, Y; Bon, F; Devy, L; Beck, H; Scholz, D; Acker, T; DiPalma, T; Dewerchin, M; Noel, A; Stalmans, I; Barra, A; Blacher, S; Vandendriessche, T; Ponten, A; Eriksson, U; Plate, KH; Foidart, JM; Schaper, W; Charnock-Jones, DS; Hicklin, DJ; Herbert, JM; Collen, D; Persico, MG
      Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathologicalconditions

      NATURE MEDICINE
    7. Angelillo-Scherrer, A; de Frutos, PG; Aparicio, C; Melis, E; Savi, P; Lupu, F; Arnout, J; Dewerchin, M; Hoylaerts, MF; Herbert, M; Collen, D; Dahlback, B; Carmeliet, P
      Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

      NATURE MEDICINE
    8. Carmeliet, P
      Jeffrey Michael Isner 1947-2001 - Obituary

      NATURE MEDICINE
    9. Nicole, O; Docagne, F; Ali, C; Margaill, I; Carmeliet, P; MacKenzie, ET; Vivien, D; Buisson, A
      The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

      NATURE MEDICINE
    10. Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P
      Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

      NATURE GENETICS
    11. Dor, Y; Camenisch, T; Itin, A; Fishman, GI; McDonald, JA; Carmeliet, P; Keshet, E
      A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects

      DEVELOPMENT
    12. Lambert, V; Munaut, C; Noel, A; Frankenne, F; Bajou, K; Gerard, R; Carmeliet, P; Defresne, MP; Foidart, JM; Rakic, JM
      Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

      FASEB JOURNAL
    13. Rajantie, I; Ekman, N; Iljin, K; Arighi, E; Gunji, Y; Kaukonen, J; Palotie, A; Dewerchin, M; Carmeliet, P; Alitalo, K
      Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium

      MOLECULAR AND CELLULAR BIOLOGY
    14. Holst-Hansen, C; Low, JA; Stephens, RW; Johnson, MD; Carmeliet, P; Frandsen, TL; Brunner, N; Dickson, RB
      Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat

      BREAST CANCER RESEARCH AND TREATMENT
    15. Carmeliet, P
      Cardiovascular biology - Creating unique blood vessels

      NATURE
    16. Van Cromphaut, SJ; Dewerchin, M; Hoenderop, JGJ; Stockmans, I; Van Herck, E; Kato, S; Bindels, RJM; Collen, D; Carmeliet, P; Bouillon, R; Carmeliet, G
      Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    17. Yang, YH; Carmeliet, P; Hamilton, JA
      Tissue-type plasminogen activator deficiency exacerbates arthritis

      JOURNAL OF IMMUNOLOGY
    18. Bajou, K; Masson, V; Gerard, RD; Schmitt, PM; Albert, V; Praus, M; Lund, LR; Frandsen, TL; Brunner, N; Dano, K; Fusenig, NE; Weidle, U; Carmeliet, G; Loskutoff, D; Collen, D; Carmeliet, P; Foidart, JM; Noel, AS
      The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies

      JOURNAL OF CELL BIOLOGY
    19. Brusselmans, K; Bono, F; Maxwell, P; Dor, Y; Dewerchin, M; Collen, D; Herbert, JM; Carmeliet, P
      Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Yiou, R; Delmas, V; Carmeliet, P; Gherardi, RK; Barlovatz-Meimon, G; Chopin, DK; Abbou, CC; Lefaucheur, JP
      The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse

      JOURNAL OF ANATOMY
    21. Heyen, MV; Heymans, S; Antoons, G; Reed, T; Periasamy, M; Awede, B; Lebacq, J; Vangheluwe, P; Dewerchin, M; Collen, D; Sipido, K; Carmeliet, P; Wuytack, F
      Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart

      CIRCULATION RESEARCH
    22. Levi, M; Moons, L; Bouche, A; Shapiro, SD; Collen, D; Carmeliet, P
      Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice

      CIRCULATION
    23. Conway, EM; Collen, D; Carmeliet, P
      Molecular mechanisms of blood vessel growth

      CARDIOVASCULAR RESEARCH
    24. Kadambi, A; Carreira, CM; Yun, C; Padera, TP; Dolmans, DEJGJ; Carmeliet, P; Fukumura, D; Jain, RK
      Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF-A

      CANCER RESEARCH
    25. Frandsen, TL; Holst-Hansen, C; Nielsen, BS; Christensen, IJ; Nyengaard, JR; Carmeliet, P; Brunner, N
      Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model

      CANCER RESEARCH
    26. Lluis, F; Roma, J; Suelves, M; Parra, M; Aniorte, G; Gallardo, E; Illa, I; Rodriguez, L; Hughes, SM; Carmeliet, P; Roig, M; Munoz-Canoves, P
      Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo

      BLOOD
    27. Melis, E; Moons, L; De Mol, M; Herbert, JM; Mackman, N; Collen, D; Carmeliet, P; Dewerchin, M
      Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    28. Herbert, JM; de Prost, D; Ollivier, V; Melis, E; Carmeliet, P
      Tissue factor is not involved in the mitogenic activity of factor VIIa

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    29. Yu, JL; Rak, JW; Carmeliet, P; Nagy, A; Kerbel, RS; Coomber, BL
      Heterogeneous vascular dependence of tumor cell populations

      AMERICAN JOURNAL OF PATHOLOGY
    30. Carmeliet, P
      Mechanisms of angiogenesis and arteriogenesis

      NATURE MEDICINE
    31. Li, J; Post, M; Volk, R; Gao, YH; Li, M; Metais, C; Sato, K; Tsai, J; Aird, W; Rosenberg, RD; Hampton, TG; Li, JY; Sellke, F; Carmeliet, P; Simons, M
      PR39, a peptide regulator of angiogenesis (vol 6, pg 49, 2000)

      NATURE MEDICINE
    32. Carmeliet, P
      VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

      NATURE MEDICINE
    33. Li, J; Post, M; Volk, R; Gao, Y; Li, M; Metais, C; Sato, K; Tsai, J; Aird, W; Rosenberg, RD; Hampton, TG; Li, JY; Sellke, F; Carmeliet, P; Simons, M
      PR39, a peptide regulator of angiogenesis

      NATURE MEDICINE
    34. Dewerchin, M; Liang, Z; Moons, L; Carmeliet, P; Castellino, FJ; Collen, D; Rosen, ED
      Blood coagulation factor x deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice

      THROMBOSIS AND HAEMOSTASIS
    35. Jacquemin, P; Durviaux, SM; Jensen, J; Godfraind, C; Gradwohl, G; Guillemot, F; Madsen, OD; Carmeliet, P; Dewerchin, M; Collen, D; Rousseau, GG; Lemaigre, FP
      Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine genengn3

      MOLECULAR AND CELLULAR BIOLOGY
    36. Carmeliet, P
      Developmental biology - One cell, two fates

      NATURE
    37. Carmeliet, P; Jain, RK
      Angiogenesis in cancer and other diseases

      NATURE
    38. Carmeliet, P; Collen, D
      Transgenic mouse models in angiogenesis and cardiovascular disease

      JOURNAL OF PATHOLOGY
    39. Uhrin, P; Dewerchin, M; Hilpert, M; Chrenek, P; Schofer, C; Zechmeister-Machhart, M; Kronke, G; Vales, A; Carmeliet, P; Binder, BR; Geiger, M
      Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility

      JOURNAL OF CLINICAL INVESTIGATION
    40. Carmeliet, P
      Proteinases in cardiovascular aneurysms and rupture: targets for therapy?

      JOURNAL OF CLINICAL INVESTIGATION
    41. Baes, M; Huyghe, S; Carmeliet, P; Declercq, PE; Collen, D; Mannaerts, GP; Van Veldhoven, PP
      Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Carmeliet, P
      Fibroblast growth factor-1 stimulates branching and survival of myocardialarteries - A goal for therapeutic angiogenesis?

      CIRCULATION RESEARCH
    43. Tsuzuki, Y; Fukumura, D; Oosthuyse, B; Koike, C; Carmeliet, P; Jain, RK
      Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha -> hypoxia response element -> VEGF cascade differentially regulates vascular response and growth rate in tumors

      CANCER RESEARCH
    44. Kataoka, K; Asai, T; Taneda, M; Ueshima, S; Matsuo, O; Kuroda, R; Kawabata, A; Carmeliet, P
      Roles of urokinase type plasminogen activator in a brain stab wound

      BRAIN RESEARCH
    45. Bautch, VL; Redick, SD; Scalia, A; Harmaty, M; Carmeliet, P; Rapoport, R
      Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A

      BLOOD
    46. Creemers, E; Cleutjens, J; Smits, J; Heymans, S; Moons, L; Collen, D; Daemen, M; Carmeliet, P
      Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction

      AMERICAN JOURNAL OF PATHOLOGY
    47. Noel, A; Bajou, K; Masson, V; Devy, L; Frankenne, F; Rakic, JM; Lambert, V; Carmeliet, P; Foidart, JM
      Regulation of cancer invasion and vascularization by plasminogen activatorinhibitor-1

      FIBRINOLYSIS & PROTEOLYSIS
    48. Plow, EF; Ploplis, VA; Carmeliet, P; Collen, D
      Plasminogen and cell migration in vivo

      FIBRINOLYSIS & PROTEOLYSIS
    49. Hansson, G; Carmeliet, P; Pepper, M
      Tribute to Werner Risau - December 18, 1953 December 13, 1998 - In Memoriam

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    50. Tabrizi, P; Wang, L; Seeds, N; McComb, JG; Yamada, S; Griffin, JH; Carmeliet, P; Weiss, MH; Zlokovic, BV
      Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model - Studies in tPA-deficient mice and wild-type mice on a matched genetic background

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    51. Carmeliet, P; Ng, YS; Nuyens, D; Theilmeier, G; Brusselmans, K; Cornelissen, I; Ehler, E; Kakkar, VV; Stalmans, I; Mattot, V; Perriard, JC; Dewerchin, M; Flameng, W; Nagy, A; Lupu, F; Moons, L; Collen, D; D'Amore, PA; Shima, DT
      Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)

      NATURE MEDICINE
    52. Heymans, S; Luttun, A; Nuyens, D; Theilmeier, G; Creemers, E; Moons, L; Dyspersin, GD; Cleutjens, JPM; Shipley, M; Angellilo, A; Levi, M; Nube, O; Baker, A; Keshet, E; Lupu, F; Herbert, JM; Smits, JFM; Shapiro, SD; Baes, M; Borgers, M; Collen, D; Daemen, MJAP; Carmeliet, P
      Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

      NATURE MEDICINE
    53. Lijnen, HR; Lupu, F; Moons, L; Carmeliet, P; Goulding, D; Collen, D
      Temporal and topographic matrix metalloproteinase expression after vascular injury in mice

      THROMBOSIS AND HAEMOSTASIS
    54. Kataoka, K; Asai, T; Taneda, M; Ueshima, S; Matsuo, O; Kuroda, R; Carmeliet, P; Collen, D
      Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient mice

      NEUROSCIENCE LETTERS
    55. Carmeliet, P; Lampugnani, MG; Moons, L; Breviario, F; Compernolle, V; Bono, F; Balconi, G; Spagnuolo, R; Oosthuyse, B; Dewerchin, M; Zanetti, A; Angellilo, A; Mattot, V; Nuyens, D; Lutgens, E; Clotman, F; de Ruiter, MC; Gittenberger-de Groot, A; Poelmann, R; Lupu, F; Herbert, JM; Collen, D; Dejana, E
      Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

      CELL
    56. Carmeliet, P; Collen, D
      New developments in the molecular biology of coagulation and fibrinolysis

      ANTITHROMBOTICS
    57. Carmeliet, P; Collen, D
      Role of vascular endothelial growth factor and vascular endothelial growthfactor receptors in vascular development

      VASCULAR GROWTH FACTORS AND ANGIOGENESIS
    58. Carmeliet, P
      Developmental biology - Controlling the cellular brakes

      NATURE
    59. Erlich, J; Parry, GCN; Fearns, C; Muller, M; Carmeliet, P; Luther, T; Mackman, N
      Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    60. Chan, JCY; Carmeliet, P; Moons, L; Rosen, ED; Huang, ZF; Broze, GJ; Collen, D; Castellino, FJ
      Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit

      JOURNAL OF CLINICAL INVESTIGATION
    61. Ny, A; Leonardsson, G; Hagglund, AC; Hagglof, P; Ploplis, VA; Carmeliet, P; Ny, T
      Ovulation in plasminogen-deficient mice

      ENDOCRINOLOGY
    62. Shi, CW; Patel, A; Zhang, D; Wang, H; Carmeliet, P; Reed, GL; Lee, ME; Haber, E; Sibinga, NES
      Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis

      CIRCULATION RESEARCH
    63. Zhu, YH; Carmeliet, P; Fay, WP
      Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance

      CIRCULATION
    64. Nagai, N; De Mol, M; Lijnen, HR; Carmeliet, P; Collen, D
      Role of plasminogen system components in focal cerebral ischemic infarction - A gene targeting and gene transfer study in mice

      CIRCULATION
    65. Conway, EM; Pollefeyt, S; Cornelissen, J; DeBaere, I; Steiner-Mosonyi, M; Weitz, JI; Weiler-Guettler, H; Carmeliet, P; Collen, D
      Structure-function analyses of thrombomodulin by gene-targeting in mice: The cytoplasmic domain is not required for normal fetal development

      BLOOD
    66. Carmeliet, P; Collen, D
      Targeted gene manipulation and gene transfer to study vascular biology

      MODERN VISUALISATION OF THE ENDOTHELIUM
    67. HERBERT JM; CARMELIET P
      UROKINASE MEDIATES BFGF-INDUCED VASCULAR SMOOTH-MUSCLE CELL-MIGRATIONUNDER THE CONTROL OF TGF-BETA

      FIBRINOLYSIS & PROTEOLYSIS
    68. CARMELIET P; COLLEN D
      MOLECULES IN FOCUS - TISSUE FACTOR

      International journal of biochemistry & cell biology
    69. LIJNEN HR; VANHOEF B; LUPU F; MOONS L; CARMELIET P; COLLEN D
      FUNCTION OF THE PLASMINOGEN PLASMIN AND MATRIX METALLOPROTEINASE SYSTEMS AFTER VASCULAR INJURY IN MICE WITH TARGETED INACTIVATION OF FIBRINOLYTIC SYSTEM GENES/

      Arteriosclerosis, thrombosis, and vascular biology
    70. BAJOU K; NOEL A; GERARD RD; MASSON V; BRUNNER N; HOLSTHANSEN C; SKOBE M; FUSENIG NE; CARMELIET P; COLLEN D; FOIDART JM
      ABSENCE OF HOST PLASMINOGEN-ACTIVATOR INHIBITOR-1 PREVENTS CANCER INVASION AND VASCULARIZATION

      Nature medicine
    71. LIANG Z; COOPER A; DEFORD ME; CARMELIET P; COLLEN D; CASTELLINO FJ; ROSEN ED
      CLONING AND CHARACTERIZATION OF A CDNA-ENCODING MURINE COAGULATION-FACTOR-X

      Thrombosis and haemostasis
    72. JALBERT LR; ELLIOT D; LISSENS A; CARMELIET P; COLLEN D; CASTELLINO FJ
      NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE GENE ENCODINGANTICOAGULANT PROTEIN-C

      Thrombosis and haemostasis
    73. CREEMERS EEJM; DAEMEN MJAP; CLEUTJENS JPM; SMITS JFM; MOONS L; COLLEN D; CARMELIET P
      PLASMINOGEN DEFICIENCY LEADS TO STAGNANT WOUND-HEALING FOLLOWING MYOCARDIAL-INFARCTION IN MICE

      Hypertension
    74. CARMELIET P; COLLEN D
      VASCULAR DEVELOPMENT AND DISORDERS - MOLECULAR ANALYSIS AND PATHOGENIC INSIGHTS

      Kidney international
    75. CARMELIET P; COLLEN D
      DEVELOPMENT AND DISEASE IN PROTEINASE-DEFICIENT MICE - ROLE OF THE PLASMINOGEN, MATRIX METALLOPROTEINASE AND COAGULATION SYSTEM

      Thrombosis research
    76. CARMELIET P; DOR Y; HERBERT JM; FUKUMURA D; BRUSSELMANS K; DEWERCHIN M; NEEMAN M; BONO F; ABRAMOVITCH R; MAXWELL P; KOCH CJ; RATCLIFFE P; MOONS L; JAIN RK; COLLEN D; KESHERT E
      ROLE OF HIF-1-ALPHA IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATIONAND TUMOR ANGIOGENESIS (VOL 394, PG 485, 1998)

      Nature
    77. CARMELIET P; DOR Y; HERBERT JM; FUKUMURA D; BRUSSELMANS K; DEWERCHIN M; NEEMAN M; BONO F; ABRAMOVITCH R; MAXWELL P; KOCH CJ; RATCLIFFE P; MOONS L; JAIN RK; COLLEN D; KESHET E
      ROLE OF HIF-1-ALPHA OR IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATION AND TUMOR ANGIOGENESIS

      Nature
    78. CARMELIET P
      MOLECULAR ANALYSIS, VIA GENE TARGETING AND GENE-TRANSFER, OF BLOOD-VESSEL FORMATION AND DISORDERS

      Journal of physiology
    79. JENSEN PJ; CARMELIET P; COLLEN D; LAVKER RM
      UROKINASE PLASMINOGEN-ACTIVATOR PROMOTES KERATINOCYTE PROLIFERATION IN-VIVO

      Journal of investigative dermatology
    80. JALBERT LR; ROSEN ED; MOONS L; CHAN JCY; CARMELIET P; COLLEN D; CASTELLINO FJ
      INACTIVATION OF THE GENE FOR ANTICOAGULANT PROTEIN-C CAUSES LETHAL PERINATAL CONSUMPTIVE COAGULOPATHY IN MICE

      The Journal of clinical investigation
    81. PINSKY DJ; LIAO H; LAWSON CA; YAN SF; CHEN JX; CARMELIET P; LOSKUTOFF DJ; STERN DM
      COORDINATED INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND INHIBITION OF PLASMINOGEN-ACTIVATOR GENE-EXPRESSION BY HYPOXIA PROMOTES PULMONARY VASCULAR FIBRIN DEPOSITION

      The Journal of clinical investigation
    82. MOONS L; SHI CW; PLOPLIS V; PLOW E; HABER E; COLLEN D; CARMELIET P
      REDUCED TRANSPLANT ARTERIOSCLEROSIS IN PLASMINOGEN-DEFICIENT MICE

      The Journal of clinical investigation
    83. PARRY GCN; ERLICH JH; CARMELIET P; LUTHER T; MACKMAN N
      LOW-LEVELS OF TISSUE FACTOR ARE COMPATIBLE WITH DEVELOPMENT AND HEMOSTASIS IN MICE

      The Journal of clinical investigation
    84. CARMELIET P; MOONS L; DEWERCHIN M; ROSENBERG S; HERBERT JM; LUPU F; COLLEN D
      RECEPTOR-INDEPENDENT ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PERICELLULAR PLASMIN AND MATRIX METALLOPROTEINASE PROTEOLYSIS DURING VASCULAR WOUND-HEALING IN MICE

      The Journal of cell biology
    85. CREEMERS EEJM; DAEMEN MJAP; CLEUTJENS JPM; SMITS JFM; MOONS L; COLLEN D; CARMELIET P
      COMPLETE INHIBITION OF CARDIAC WOUND-HEALING AFTER MYOCARDIAL-INFARCTION IN PLASMINOGEN DEFICIENT MICE

      Circulation
    86. FARREHI PM; OZAKI CK; CARMELIET P; FAY WP
      REGULATION OF ARTERIAL THROMBOLYSIS BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE

      Circulation
    87. CARMELIET P; MOONS L; COLLEN D
      MOUSE MODELS OF ANGIOGENESIS, ARTERIAL-STENOSIS, ATHEROSCLEROSIS AND HEMOSTASIS

      Cardiovascular Research
    88. PLOPLIS VA; FRENCH EL; CARMELIET P; COLLEN D; PLOW EF
      PLASMINOGEN DEFICIENCY DIFFERENTIALLY AFFECTS RECRUITMENT OF INFLAMMATORY CELL-POPULATIONS IN MICE

      Blood
    89. CARMELIET P
      INSIGHTS FROM GENE-INACTIVATION STUDIES OF THE COAGULATION AND PLASMINOGEN

      Fibrinolysis & proteolysis
    90. CARMELIET P; MOONS L; LIJNEN R; BAES M; LEMAITRE V; TIPPING P; DREW A; EECKHOUT Y; SHAPIRO S; LUPU F; COLLEN D
      UROKINASE-GENERATED PLASMIN ACTIVATES MATRIX METALLOPROTEINASES DURING ANEURYSM FORMATION

      Nature genetics
    91. BAES M; GRESSENS P; BAUMGART E; CARMELIET P; CASTEELS M; FRANSEN M; EVRARD P; FAHIMI D; DECLERCQ PE; COLLEN D; VANVELDHOVEN PP; MANNAERTS GP
      A MOUSE MODEL FOR ZELLWEGER-SYNDROME

      Nature genetics
    92. CARMELIET P; COLLEN D
      GENETIC-ANALYSIS OF BLOOD-VESSEL FORMATION - ROLE OF ENDOTHELIAL VERSUS SMOOTH-MUSCLE CELLS

      Trends in cardiovascular medicine
    93. CARMELIET P; COLLEN D
      MOLECULAR-GENETICS OF THE FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEMOSTASIS, THROMBOGENESIS, RESTENOSIS AND ATHEROSCLEROSIS

      Current opinion in lipidology
    94. CARMELIET P; COLLEN D
      MOLECULAR ANALYSIS OF BLOOD-VESSEL FORMATION AND DISEASE

      American journal of physiology. Heart and circulatory physiology
    95. CARMELIET P; DIPALMA T; BARRA A; MOONS L; OOSTHUYZE B; BRUSSELMANS K; COLLEN D; PERSICO G
      IMPAIRED WOUND-HEALING IN MICE LACKING PLACENTAL GROWTH-FACTOR

      Thrombosis and haemostasis
    96. CARMELIET P; MOONS L; DREW A; TIPPING P; LUPU F; LIJNEN HR; COLLEN D
      LACK OF ANEURYSM FORMATION IN ATHEROSCLEROTIC AORTA FROM UROKINASE DEFICIENT MICE

      Thrombosis and haemostasis
    97. ROSEN E; CHAN JCY; IDUSOGIE E; CARMELIET P; CASTELLINO F; COLLEN D
      GENERATION AND CHARACTERIZATION OF FVII DEFICIENT MICE

      Thrombosis and haemostasis
    98. STELLA M; DIPIETRO N; DIODATO E; DOSSI C; NARDULLI A; DONATI MB; DEWERCHIN M; CARMELIET P; POGGI A
      REDUCED DISSEMINATION OF LEWIS LUNG-CARCINOMA IN MICE GENETICALLY DEFICIENT FOR UROKINASE-TYPE (U-PA) PLASMINOGEN-ACTIVATOR

      Thrombosis and haemostasis
    99. JALBERT LR; ROSEN ED; CARMELIET P; COLLEN D; CASTELLINO FJ
      NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE PROTEIN-C GENE FOR TARGETED GENE REPLACEMENT

      Thrombosis and haemostasis
    100. PLOPLIS V; BUSSUTIL S; FRENCH E; TANG L; CARMELIET P; COLLEN D; PLOW E
      THE INFLAMMATORY RESPONSE TO BIOPOLYMER IMPLANTS IN PLASMINOGEN DEFICIENT MICE

      Thrombosis and haemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 19:08:32